C. Llamoso

M. Buti, F. Durand, K. Brown, 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals

D. Cella, M. Murray, S. Anderson, 2021, The Patient - Patient-Centered Outcomes Research.

Antiviral efficacy of entecavir in nucleos(t)ide‐naïve patients of Black/African descent with chronic hepatitis B

M. Schechter, R. Paraná, C. Llamoso, 2014, Journal of viral hepatitis.

535 SAFETY AND EFFICACY OF ENTECAVIR IN PATIENTS RECEIVING LIVER TRANSPLANT DUE TO CHRONIC HEPATITIS B

F. Durand, K. Brown, M. Charlton, 2012 .

Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1

M. Kozal, J. Aberg, A. Streinu-Cercel, 2021, AIDS.

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection.

M. Kozal, P. Cahn, J. Aberg, 2020, The New England journal of medicine.

Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants

N. Thakkar, B. Vakkalagadda, C. Llamoso, 2022, Antimicrobial agents and chemotherapy.

Evaluation of the pharmacokinetic drug-drug interaction between the antiretroviral agents fostemsavir and maraviroc: a single-sequence crossover study in healthy participants

C. Llamoso, M. Magee, M. Wire, 2022, HIV research & clinical practice.

Prevalence of gp160 polymorphisms known to be related to decreased susceptibility to temsavir in different subtypes of HIV-1 in the Los Alamos National Laboratory HIV Sequence Database

B. Foley, M. Krystal, E. Arnoult, 2021, The Journal of antimicrobial chemotherapy.

2500. Fostemsavir Drug–Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Heavily Treatment Experienced HIV-1-Infected Patients

P. Gorycki, C. Llamoso, M. Magee, 2019, Open Forum Infectious Diseases.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial

Samit R. Joshi, J. Bogner, J. Molina, 2018, PloS one.

Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants

Ming Chang, C. Llamoso, M. Magee, 2019, British journal of clinical pharmacology.